ライフサイエンスコーパス: bacteriuria

1 ctal swabs; with separate subanalysis on GBS bacteriuria).

2 re there is evidence of ascending infection (bacteriuria).

3 , this treatment failed to prevent relapsing bacteriuria.

4 ociated with UTI episodes and with levels of bacteriuria.

5 re testing for and treatment of asymptomatic bacteriuria.

6 tested for bacteremia within +/-1 day of the bacteriuria.

7 of chronic cystitis as defined by persistent bacteriuria.

8 events the development of relapsing bouts of bacteriuria.

9 fits and harms of screening for asymptomatic bacteriuria.

10 rains (53% of isolates) than in asymptomatic bacteriuria (32%) or fecal/commensal (12.5%) strains.

11 mensal, 32 animal commensal, 54 asymptomatic bacteriuria, 45 complicated UTI, 38 uncomplicated cystit

12 in those associated with catheter-associated bacteriuria (58%) and in fecal strains (22%) (P < 0.001)

13 Among 2225 episodes of bacteriuria, 64% were classified as ASB.

14 ovariectomized mice had significantly higher bacteriuria, a more robust inflammatory response, and in

15 inary tract infection (UTI) and asymptomatic bacteriuria (AB) in relation to diabetes mellitus and it

16 ce and clinical significance of asymptomatic bacteriuria (AB) in women with autoimmune rheumatic dise

17 ttle is known about the role of asymptomatic bacteriuria (AB) treatment in young women affected by re

18 UTIs) are routinely treated for asymptomatic bacteriuria (AB), but the consequences of this procedure

19 inoculation with the prototype asymptomatic bacteriuria (ABU) strain E. coli 83972, and inhibition w

20 about bacteria associated with asymptomatic bacteriuria (ABU) with regard to urinary tract colonizat

21 oli isolates from patients with asymptomatic bacteriuria (ABU).

22 s both symptomatic cystitis and asymptomatic bacteriuria (ABU); however, growth characteristics of S.

23 The majority of bacteriuria among inpatient veterans is due to ASB with

24 We investigated the prevalence of bacteriuria among pregnant women with and without UTI sy

25 ct confounding due to untreated asymptomatic bacteriuria among women who were not given a diagnosis o

26 rther assess the effect of decolonisation on bacteriuria and candiduria in patients admitted to ICUs.

27 d by an increased prevalence of asymptomatic bacteriuria and frequent use of urinary catheters.

28 Asymptomatic bacteriuria and symptomatic urinary tract infections (UT

29 s, 49 from patients with catheter-associated bacteriuria, and 27 from fecal samples).

30 r period were grouped according to symptoms, bacteriuria, and urinalysis.

31 sions on which a culture showed asymptomatic bacteriuria, as compared with 1 percent of occasions whe

32 ic overuse through treatment of asymptomatic bacteriuria (ASB) and long durations of therapy for symp

33 Differential diagnosis of asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) is b

34 contamination, but the role of asymptomatic bacteriuria (ASB) before elective surgery and the subseq

35 with the clinical condition of asymptomatic bacteriuria (ASB), characterized by significant bacteria

36 person-years; RR, 0.67; 95% CI, 0.32-1.40), bacteriuria associated with multidrug-resistant gram-neg

37 human bladder with a prototypic asymptomatic bacteriuria-associated bacterium, Escherichia coli 83972

38 The sensitivities for Gram-negative bacteriuria at >/=10(4) CFU/ml and >/=10(5) CFU/ml were

39 of cultures) were not predictive of bladder bacteriuria at any colony count (Spearman's r=0.322 for

40 t significantly decreases candiduria and any bacteriuria, but not for women.

41 Bacteriuria commonly precedes UTI and is often treated w

42 Bacteriuria contributes to antibiotic overuse through tr

43 ix months for the occurrence of asymptomatic bacteriuria (defined as at least 10(5) colony-forming un

44 5 (sensitivity 86%) samples with significant bacteriuria, defined as the presence of a Gram-negative

45 Enterococcus faecalis, and Candida albicans (bacteriuria developed at a mean of 2-5 days vs. 9-34 day

46 We tested RapidBac, a rapid immunoassay for bacteriuria developed by Silver Lake Research Corporatio

47 phore systems was associated with increasing bacteriuria during cystitis.

48 tream urine was highly predictive of bladder bacteriuria even at very low counts, with a positive pre

49 te pyelonephritis, while other patients with bacteriuria exhibit an asymptomatic carrier state simila

50 e asymptomatic young women with demonstrated bacteriuria from January 2005 to December 2009 were pros

51 nt evidence helps differentiate asymptomatic bacteriuria from symptomatic UTI.

52 rUTI, with similar increases in same-strain bacteriuria (from 7% to 69%), leukocyte esterase (from 3

53 Outcomes included high-level bacteriuria (>/=50 000 colony forming units [CFU]/mL) wi

54 cystitis, which is manifested as persistent bacteriuria, high bladder bacterial burdens, and chronic

55 chronic cystitis, manifesting as persistent bacteriuria, high-titer bladder bacterial burdens, and c

56 Main Outcomes and Measures: Presence of bacteriuria (ie, at least 105 colony-forming units [CFUs

57 ensitivity and specificity for gram-positive bacteriuria in 404 urine specimens were 91.2 and 99.2%,

58 f high-count (>/=10(4) CFU/ml) gram-negative bacteriuria in 487 urine specimens were 98.2 and 97.4%,

59 e pyuria in 19 cases (11%), and no pyuria or bacteriuria in 9 cases (5%).

60 iuria (the proportion of urine cultures with bacteriuria in asymptomatic women) was 5 percent (95 per

61 ), catheter-associated UTI, and asymptomatic bacteriuria in both women and men.

62 Preterm birth was associated with GBS bacteriuria in cohort studies (RR, 1.98 [95% CI, 1.45-2.

63 antimicrobial urinary catheters can prevent bacteriuria in hospitalized patients during short-term c

64 Asymptomatic bacteriuria in older women should not be treated.

65 tinues to support screening for asymptomatic bacteriuria in pregnant women, but not in other groups o

66 We analyzed the presence of bacteriuria in relation to the clinical symptoms.

67 ared to the standard streak method to detect bacteriuria in specimens submitted to the diagnostic lab

68 on, which may suggest the triggering role of bacteriuria in the occurrence of edematous episodes.

69 Our study intended to evaluate bacteriuria in the urinalysis of patients with C1-INH-HA

70 Asymptomatic bacteriuria in young women is common but rarely persists

71 ysis for trauma patients with no evidence of bacteriuria, including those who suffered mucosal injuri

72 Chronic bacteriuria is a common occurrence among spinal-cord inj

73 Asymptomatic bacteriuria is common in young women, but little is know

74 Asymptomatic bacteriuria is common, and screening for this condition

75 Asymptomatic bacteriuria is transient in older women, often resolves

76 regnant women with diabetes for asymptomatic bacteriuria is unlikely to produce benefits.

77 E. coli 83972 is an asymptomatic bacteriuria isolate successfully used as a prophylactic

78 Low-count gram-negative bacteriuria (<10(4) CFU/ml) was detected by the filter p

79 tions (UTIs), yet large-scale evaluations of bacteriuria management among inpatients are lacking.

80 setting, is very difficult, as asymptomatic bacteriuria may be difficult to differentiate from sympt

81 The RapidBac test for bacteriuria may be effective as an aid in the point-of-c

82 P. mirabilis bacteriuria may lead to acute pyelonephritis, fever, and

83 Atg16L1-deficient mice (Atg16L1(HM)) cleared bacteriuria more rapidly and thoroughly than controls an

84 cutive urine samples (1.1%): 62 patients had bacteriuria of >10(7) CFU/liter and at least one UTI sym

85 l lower genitourinary tract abnormalities of bacteriuria or bacterial prostatitis by traditional clin

86 w evidence on screening men for asymptomatic bacteriuria or on harms of screening was found.

87 e cystitis, recurrent cystitis, asymptomatic bacteriuria, or pyelonephritis could progress through th

88 cranberry capsules once a day on presence of bacteriuria plus pyuria among women residing in nursing

89 6.4 years [SD, 8.2], 90.3% white, 31.4% with bacteriuria plus pyuria at baseline), 147 completed the

90 omen aged 65 years or older, with or without bacteriuria plus pyuria at baseline, residing in 21 nurs

91 no significant difference in the presence of bacteriuria plus pyuria between the treatment group vs t

92 Unadjusted results showed the presence of bacteriuria plus pyuria in 25.5% (95% CI, 18.6%-33.9%) o

93 Importance: Bacteriuria plus pyuria is highly prevalent among older

94 in no significant difference in presence of bacteriuria plus pyuria over 1 year.

95 lences of periurethral rUTI strain carriage, bacteriuria, pyuria, and intercourse dramatically increa

96 Recurrent UTIs preceded by bacteriuria, pyuria, and symptoms were caused by strains

97 Control group bacteriuria rate, control catheter type (latex vs. silic

98 oping symptomatic UTI (primary end point) or bacteriuria (secondary end point) were extracted by usin

99 Asymptomatic bacteriuria should be differentiated from symptomatic UT

100 In general, asymptomatic bacteriuria should not be treated, and treatment of CAUT

101 h a commensal, potentially probiotic E. coli bacteriuria strain.

102 ntly higher (14.51 vs 8.63) in patients with bacteriuria than in those without (P < 0.0001).

103 dematous attacks was higher in patients with bacteriuria than in those without (P = 0.019, P = 0.022,

104 ohort study of adult inpatients with E. coli bacteriuria that were tested for bacteremia within +/-1

105 The prevalence of asymptomatic bacteriuria (the proportion of urine cultures with bacte

106 al spectrum of UTIs ranges from asymptomatic bacteriuria, to symptomatic and recurrent UTIs, to sepsi

107 Asymptomatic bacteriuria was associated with the same risk factors as

108 Bacteremia secondary to E. coli bacteriuria was frequent (15%) in those tested for it.

109 ith 1 percent of occasions when asymptomatic bacteriuria was not found (P<0.001).

110 e test, detecting the absence of significant bacteriuria, was 94%.

111 In patients with bacteriuria, we found a higher incidence of edema format

112 baseline hazard ratios (HRs) for high-level bacteriuria were 1.02 (95% CI 0.88-1.18) for screening o

113 Inpatients with bacteriuria were classified as asymptomatic or symptomat

114 Bacteriuria with any CFU/mL was also reduced in men in t

115 All trials suggested protection against bacteriuria with test catheter use.

116 Persistent asymptomatic bacteriuria with the same E. coli strain was rare.

117 level candiduria (>/=50 000 CFU/mL), and any bacteriuria with uropathogens.

118 ssary antimicrobial therapy for asymptomatic bacteriuria without significant additional laboratory wo

119 antimicrobial prescriptions for asymptomatic bacteriuria, without any significant impact on incidence